Koers Morepen Laboratories Limited NSE India S.E.
Aandelen
MOREPENLAB
INE083A01026
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
49,65 INR | -1,29% | -2,65% | +2,27% |
Omzet 2022 | 15,56 mld. 187 mln. 173 mln. | Omzet 2023 | 14,22 mld. 171 mln. 159 mln. | Marktkapitalisatie | 13,13 mld. 157 mln. 146 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 1,02 mld. 12,2 mln. 11,34 mln. | Nettowinst (verlies) 2023 | 387 mln. 4,64 mln. 4,31 mln. | EV/omzet 2022 | 1,2 x |
Nettoschuld 2022 | 1,17 mld. 14,09 mln. 13,09 mln. | Nettoschuld 2023 | 34,98 mln. 420K 390K | EV/omzet 2023 | 0,93 x |
K/w-verhouding 2022 |
18,7
x | K/w-verhouding 2023 |
33,4
x | Werknemers | 1.649 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 52,17% |
1 dag | -1,29% | ||
1 week | -2,65% | ||
Lopende maand | -0,80% | ||
1 maand | +2,58% | ||
3 maanden | -6,05% | ||
6 maanden | +37,15% | ||
Lopend jaar | +2,27% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sushil Suri
CEO | Chief Executive Officer | 60 | 01-02-92 |
Director of Finance/CFO | 57 | 03-04-02 | |
Compliance Officer | 38 | 12-11-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sanjay Suri
BRD | Director/Board Member | 55 | 13-08-19 |
Sushil Suri
CEO | Chief Executive Officer | 60 | 01-02-92 |
Sukhcharan Singh
BRD | Director/Board Member | 81 | 15-06-05 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
03-05-24 | 49,65 | -1,29% | 2 049 359 |
02-05-24 | 50,3 | +0,50% | 2 895 629 |
30-04-24 | 50,05 | -0,99% | 2 209 533 |
29-04-24 | 50,55 | -0,88% | 2 973 727 |
uitgestelde koers NSE India S.E., 03 mei 2024 om 13:43 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+26,08% | 662 mld. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. |
- Beurs
- Aandelen
- Koers 500288
- Koers MOREPENLAB